Effects of inhaled gases on the ultrasound contrast produced by microspheres containing air or perfluoropropane in anesthetized dogs

Investigative Radiology

Volumn 33, Issue 12, 1998, Pages 871-879

  Wible, James ^a   Wojdyla, Jolette ^a   Bugaj, Joseph ^a   Brandenburger, Gary ^a  

^a MALLINCKRODT PHARMACEUTICALS   (United States)

Author keywords

Inhaled gases; Ultrasound contrast media; Ultrasound imaging

Indexed keywords

ALBUNEX; FS 069; MICROSPHERE; NITROGEN; OXYGEN;

ANIMAL EXPERIMENT; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOG; ECHOGRAPHY; HEART LEFT VENTRICLE; HEART MUSCLE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032471071     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199812000-00005     Document Type: Article

References (17)

1. Goldberg BB, Liu JB, Foresberg F. Ultrasound contrast agents: A review. Ultrasound Med Biol 1994;20:319-333.
2. Crouse LJ, Cheirif J, Hanely DE, et al. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: Results of the Phase III Albunex multicenter trial. J Am Coll Cardiol 1993;22:1494-1500.
3. Schwartz KQ, Becher H, Schimpfky C, Vorwerk D, Bogdahn U, Schlief R. Doppler enhancement with SHU 508A in multiple vascular regions. Radiology 1994;193:195-201.
4. Vuille C, Nidorf M, Morrissey RL, Newell JB, Weyman AE, Picard MH. Effects of static pressure on the disappearance rate of specific echocardiographic contrast agents. J Am Soc Echocardiogr 1994; 7:347-354.
5. Correas J-M, Hélénon O, Pourcelot L, Moreau J-F. Ultrasound contrast agents, examples of blood pool agents. Acta Radiol 1997;38(suppl): 101-112.
6. Meza M, Greener Y, Hunt R, et al. Myocardial contrast echocardiography: Reliable, safe, and efficacious myocardial perfusion assessment after intravenous injections of a new echocardiographic contrast agent. Am Heart J 1996;132:871-881.
7. Mobarek, SK, Kates MA, Murgo JP, Moreno CA, Revall S, Cheirif J. Assessment of renal perfusion in a canine model using FS069, a new transpulmonary echocontrast agent. Echocardiography 1997; 14:447-453.
8. Geiser EA, Buss DD, Wible, JH Jr, et al. Evidence for a relation between inspired gas mixture and the left ventricular contrast achieved with Albunex in a canine model. Clin Cardiol 1996;19: 289-295.
9. Wible JH Jr, Wojdyla JK, Bales GL, McMullen WN, Geiser EA, Buss DD. Inhaled gases affect the ultrasound contrast produced by Albunex in anesthetized dogs. J Am Soc Echocardiogr 1996;9:442-151.
10. Van Liew HD, Conkin J, Burkard ME. The oxygen window and decompression bubbles: Estimates and significance. Aviat Space Environ Med 1993;64:859-865.
11. Braker W, Mossman AL. Matheson Gas Data Book, 6th ed. Secaucus, NJ: Matheson Gas Products, 1980:590-595.
12. Wong RF, Thompson JT. Prediction of the kinetics of disappearance of sulfur hexafluoride and perfluoropropane intraocular gas bubbles. Ophthalmology 1988;95:609-613.
13. Barrette TR, McCreery TP, Fritz TA, Matsunaga TO, Unger EC. MRX115, a novel microbubble contrast agent, provides ultrasound contrast in animals ventilated on oxygen. [abstract]. J Ultrasound Med 1995;14:S58.
14. Dittrich HC, Bales GL, Kuvelas T, Hunt RM, McFerran BA, Greener Y. Myocardial contrast echocardiography in experimental coronary artery occlusion with a new intravenously administered contrast agent. J Am Soc Echocradiogr 1995;8:465-474.
15. 99mTc-sestamibi single photon emission computed tomography. Circulation 1997;96:785-792.
16. Carson BA, Gordon HJ, Shnier CB, Horton AF, Hickey RP, Hickey RF. Effects of high arterial oxygen tension on coronary blood flow regulation and myocardial oxygen delivery. In: Vaupel P, Zander R, Burley DF, eds. Oxygen Transport to Tissue XV. New York, NY: Plenum Press, 1994:317-323.
17. Luce JM, Hopewell PC. Critical care medicine. In: Wyngaarden, JB, Smith, LH, Jr, Bennett, JC, eds. Cecil Textbook of Medicine. Philadelphia, PA: W.B. Saunders Co., 1992:2370-2380.